The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.
Washingtonians are struggling to afford already high health care costs, and those costs keep climbing. Sadly, I’ve seen this ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...
A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.
A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state. | A Minnesota analysis of providers' reported ...
The Health Resources and Services Administration Feb. 25 said it will extend the deadline to April 20 to receive comments on ...
AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
When it was passed in 1992, no one thought to mandate how hospitals and clinics would spend the deep discounts they receive on prescription drugs.
The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...
AbbVie loses bid to block Tennessee 340B law as federal court upholds state statute limiting drugmaker restrictions on contract pharmacies.
MedPage Today on MSN
Hospitals, drugmakers, and US government continue battle over 340B program
The drug discount program is under scrutiny on a variety of fronts ...
The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results